363 related articles for article (PubMed ID: 20332776)
1. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA
Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776
[TBL] [Abstract][Full Text] [Related]
2. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
[TBL] [Abstract][Full Text] [Related]
3. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
5. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
6. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
7. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
8. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
9. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
[TBL] [Abstract][Full Text] [Related]
11. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
12. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line.
Fan X; Ouyang N; Teng H; Yao H
Int J Colorectal Dis; 2011 Oct; 26(10):1279-85. PubMed ID: 21670985
[TBL] [Abstract][Full Text] [Related]
14. Cultivation and identification of colon cancer stem cell-derived spheres from the Colo205 cell line.
Li YF; Xiao B; Tu SF; Wang YY; Zhang XL
Braz J Med Biol Res; 2012 Mar; 45(3):197-204. PubMed ID: 22310487
[TBL] [Abstract][Full Text] [Related]
15. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
Yu X; Mi L; Dong J; Zou J
BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
[TBL] [Abstract][Full Text] [Related]
17. Identification and expansion of human colon-cancer-initiating cells.
Ricci-Vitiani L; Lombardi DG; Pilozzi E; Biffoni M; Todaro M; Peschle C; De Maria R
Nature; 2007 Jan; 445(7123):111-5. PubMed ID: 17122771
[TBL] [Abstract][Full Text] [Related]
18. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
19. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
20. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
